Earnings History Data for NeuroMetrix, Inc. (NURO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

NeuroMetrix, Inc.

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
22-02-2024	PM		NURO	NeuroMetrix, Inc.	3.72	-1.43	0.00	-0.72	NeuroMetrix GAAP EPS of -$1.43, revenue of $1.32B [2/22/2024 7:09 AM]	2.91	-0.26 (-8.20%)	3.30	0.13 (4.10%)	2.70 - 15.04	208,964	70,000	3,017
NeuroMetrix GAAP EPS of -$1.43, revenue of $1.32B [2/22/2024 7:09 AM]
26-10-2023	PM		NURO	NeuroMetrix, Inc.	5.59	-0.21	0.00	-0.23	NeuroMetrix reports Q3 results [10/26/2023 7:04 AM]	0.5401	-0.13 (-19.10%)	0.60	-0.07 (-10.13%)	0.47 - 2.18	212,283	10,000	22,347
NeuroMetrix reports Q3 results [10/26/2023 7:04 AM]
27-07-2023	PM		NURO	NeuroMetrix, Inc.	7.67	-0.19	0.00	-0.17	NeuroMetrix GAAP EPS of -$0.19, revenue of $1.66M [7/27/2023 7:08 AM]	0.91	-0.07 (-6.97%)	1.00	0.02 (2.23%)	0.89 - 4.73	71,274	50,000	2,464
NeuroMetrix GAAP EPS of -$0.19, revenue of $1.66M [7/27/2023 7:08 AM]
03-05-2023	PM	7:00 AM ET (May 3)	NURO	NeuroMetrix, Inc.	10.67	-0.20	0.00	-0.14	NeuroMetrix GAAP EPS of -$0.20, revenue of $1.7M [5/3/2023 7:24 AM]	1.02	-0.37 (-26.62%)	1.17	-0.22 (-15.83%)	0.97 - 5.89	317,072	20,000	21,809
NeuroMetrix GAAP EPS of -$0.20, revenue of $1.7M [5/3/2023 7:24 AM]
23-02-2023	PM	7:00 AM ET (Feb 23)	NURO	NeuroMetrix, Inc.	13.96	-0.09	0.00	-0.15	NeuroMetrix GAAP EPS of -$0.09, revenue of $1.84N [2/23/2023 7:16 AM]	1.79	0.09 (5.29%)	1.80	0.10 (5.88%)	1.33 - 5.89	23,246	40,000	740
NeuroMetrix GAAP EPS of -$0.09, revenue of $1.84N [2/23/2023 7:16 AM]
20-10-2022	PM	7:00 AM ET (Oct 20)	NURO	NeuroMetrix, Inc.	15.76	-0.23	0.00	-0.12	NeuroMetrix reports Q3 results [10/20/2022 7:04 AM]	1.88	-0.23 (-10.90%)	1.99	-0.12 (-5.69%)	1.86 - 9.49	149,007	1,890,000	21,564
NeuroMetrix reports Q3 results [10/20/2022 7:04 AM]
21-07-2022	PM	7:00 AM ET (Jul 21)	NURO	NeuroMetrix, Inc.	26.52	-0.17	0.00	-0.13	NeuroMetrix GAAP EPS of -$0.17, revenue of $2.1M [7/21/2022 7:07 AM]	3.65	-0.21 (-5.35%)	3.73	-0.13 (-3.37%)	2.70 - 38.75	78,996	60,000	6,879
NeuroMetrix GAAP EPS of -$0.17, revenue of $2.1M [7/21/2022 7:07 AM] NeuroMetrix stock dips as Q2 net loss widens, revenue falls Y/Y [7/21/2022 11:16 AM]
26-04-2022	PM	7:00 AM ET (Apr 26)	NURO	NeuroMetrix, Inc.	27.55	-0.14	0.00	-0.02	NeuroMetrix GAAP EPS of -$0.14, revenue of $2.3M [4/26/2022 7:11 AM]	3.34	-0.41 (-10.93%)	3.69	-0.06 (-1.60%)	2.58 - 38.75	132,506	100,000	6,104
NeuroMetrix GAAP EPS of -$0.14, revenue of $2.3M [4/26/2022 7:11 AM] NeuroMetrix Reports Q1 2022 Financial Results [Apr-26-22 07:00AM]
27-01-2022	PM	7:00 AM ET (Jan 27)	NURO	NeuroMetrix, Inc.	30.31	-0.15	0.00	-0.05	NeuroMetrix reports Q4 results [1/27/2022 7:06 AM]	4.09	-0.33 (-7.49%)	4.43	0.01 (0.23%)	2.58 - 38.75	215,275	7,010,000	1,729
NeuroMetrix reports Q4 results [1/27/2022 7:06 AM] NeuroMetrix Reports Q4 and Full Year 2021 Financial Results [Jan-27-22 07:00AM]
21-10-2021	PM	7:00 AM ET (Oct 21)	NURO	NeuroMetrix, Inc.	51.00	-0.12	0.00	-0.07	NeuroMetrix reports Q3 results [10/21/2021 7:14 AM]	8.34	-0.76 (-8.40%)	8.62	-0.48 (-5.27%)	1.47 - 38.75	815,007	1,150,000	75,590
NeuroMetrix reports Q3 results [10/21/2021 7:14 AM] NeuroMetrix shares fall after wider Q3 net loss [10/21/2021 10:31 AM] NeuroMetrix Names Strategic Growth Executive, Susan M. Bell, RN, BN, as Senior Vice President of Population Health & Value Based Care [Oct-20-21 09:00AM] Those who invested in NeuroMetrix (NASDAQ:NURO) a year ago are up 453% [Oct-20-21 08:50AM] NeuroMetrix Reports Q3 2021 Financial Results [Oct-21-21 07:00AM]
22-07-2021	PM	7:00 AM ET (Jul 22)	NURO	NeuroMetrix, Inc.	49.66	-0.13	0.00	-0.28	NeuroMetrix reports Q2 results [7/22/2021 7:08 AM]	24.90	4.10 (19.72%)	38.49	17.69 (85.05%)	1.39 - 38.75	48,223,008	37,190,000	12,526,461
NeuroMetrix reports Q2 results [7/22/2021 7:08 AM] NeuroMetrix stock joins Reddit-driven rally with 60% rise in Q2 revenue [7/22/2021 10:00 AM] Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson [Jul-21-21 04:35AM] NeuroMetrix Reports Q2 2021 Financial Results [Jul-22-21 07:00AM] Companies Like NeuroMetrix (NASDAQ:NURO) Can Afford To Invest In Growth [Jul-22-21 05:46AM]
22-04-2021	PM	7:00 AM ET (Apr 22)	NURO	NeuroMetrix, Inc.	12.00	-0.02	0.00	-0.45	NeuroMetrix reports Q1 results [4/22/2021 7:04 AM]	2.95	-0.08 (-2.64%)	0.0	0.0 (0.00%)	1.39 - 5.78	95,752	60,000	0
NeuroMetrix reports Q1 results [4/22/2021 7:04 AM] NeuroMetrix, Inc. to Host Earnings Call [Apr-22-21 06:45AM] NeuroMetrix Reports Q1 2021 Financial Results [Apr-22-21 07:00AM]
28-01-2021	PM	7:00 AM ET (Jan 28)	NURO	NeuroMetrix, Inc.	18.85	-0.05	0.00	0.00	NeuroMetrix reports Q4 results [1/28/2021 9:02 AM]	3.93	-0.47 (-10.68%)	4.11	-0.29 (-6.59%)	0.81 - 6.20	483,415	849,068	20,445
NeuroMetrix reports Q4 results [1/28/2021 9:02 AM] NeuroMetrix, Inc. to Host Earnings Call [Jan-28-21 05:45AM] Companies Like NeuroMetrix (NASDAQ:NURO) Are In A Position To Invest In Growth [Jan-27-21 03:22AM]
22-10-2020	PM	7:00 AM ET (Oct 22)	NURO	NeuroMetrix, Inc.	6.40	-0.07	0.00	-1.40	NeuroMetrix reports Q3 results [10/22/2020 7:11 AM]	1.60	-0.04 (-2.44%)	1.69	0.05 (3.06%)	0.81 - 6.20	139,470	269,329	14,915